Literature DB >> 26987909

The frontotemporal dementia-motor neuron disease continuum.

James R Burrell1, Glenda M Halliday1, Jillian J Kril2, Lars M Ittner1, Jürgen Götz3, Matthew C Kiernan4, John R Hodges5.   

Abstract

Early reports of cognitive and behavioural deficits in motor neuron disease might have been overlooked initially, but the concept of a frontotemporal dementia-motor neuron disease continuum has emerged during the past decade. Frontotemporal dementia-motor neuron disease is now recognised as an important dementia syndrome, which presents substantial challenges for diagnosis and management. Frontotemporal dementia, motor neuron disease, and frontotemporal dementia-motor neuron disease are characterised by overlapping patterns of TAR DNA binding protein (TDP-43) pathology, while the chromosome 9 open reading frame 72 (C9orf72) repeat expansion is common across the disease spectrum. Indeed, the C9orf72 repeat expansion provides important clues to disease pathogenesis and suggests potential therapeutic targets. Variable diagnostic criteria identify motor, cognitive, and behavioural deficits, but further refinement is needed to define the clinical syndromes encountered in frontotemporal dementia-motor neuron disease.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26987909     DOI: 10.1016/S0140-6736(16)00737-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  96 in total

1.  The Study of Language in the Amyotrophic Lateral Sclerosis - Frontotemporal Spectrum Disorder: a Systematic Review of Findings and New Perspectives.

Authors:  Marta Pinto-Grau; Orla Hardiman; Niall Pender
Journal:  Neuropsychol Rev       Date:  2018-04-28       Impact factor: 7.444

2.  CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation.

Authors:  Yazi D Ke; Gabriella Chan; Kristie Stefanoska; Carol Au; Mian Bi; Julius Müller; Magdalena Przybyla; Astrid Feiten; Emmanuel Prikas; Glenda M Halliday; Olivier Piguet; Matthew C Kiernan; Michael Kassiou; John R Hodges; Clement T Loy; John S Mattick; Arne Ittner; Jillian J Kril; Greg T Sutherland; Lars M Ittner
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

Review 3.  Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues.

Authors:  Lars M Ittner; Matthias Klugmann; Yazi D Ke
Journal:  Br J Pharmacol       Date:  2019-04-23       Impact factor: 8.739

Review 4.  Defining pre-symptomatic amyotrophic lateral sclerosis.

Authors:  Michael Benatar; Martin R Turner; Joanne Wuu
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-03-20       Impact factor: 4.092

Review 5.  Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.

Authors:  Steve Vucic; Matthew C Kiernan
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

6.  Heterogeneity of behavioural and language deficits in FTD-MND.

Authors:  Zhe Long; Muireann Irish; David Foxe; John R Hodges; Olivier Piguet; James R Burrell
Journal:  J Neurol       Date:  2021-02-20       Impact factor: 4.849

7.  Assessing behavioural changes in ALS: cross-validation of ALS-specific measures.

Authors:  Marta Pinto-Grau; Emmet Costello; Sarah O'Connor; Marwa Elamin; Tom Burke; Mark Heverin; Niall Pender; Orla Hardiman
Journal:  J Neurol       Date:  2017-06-09       Impact factor: 4.849

Review 8.  Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Authors:  Zongbing Hao; Rui Wang; Haigang Ren; Guanghui Wang
Journal:  Neurosci Bull       Date:  2020-08-29       Impact factor: 5.203

9.  Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia-motor neuron disease patients.

Authors:  Zhe Long; Muireann Irish; Olivier Piguet; Matthew C Kiernan; John R Hodges; James R Burrell
Journal:  J Neurol       Date:  2019-02-01       Impact factor: 4.849

Review 10.  Pathophysiological and diagnostic implications of cortical dysfunction in ALS.

Authors:  Nimeshan Geevasinga; Parvathi Menon; P Hande Özdinler; Matthew C Kiernan; Steve Vucic
Journal:  Nat Rev Neurol       Date:  2016-09-23       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.